265 related articles for article (PubMed ID: 37187728)
21. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
Gupta S; Su H; Agrawal S
Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
[TBL] [Abstract][Full Text] [Related]
22. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Guven DC; Sahin TK; Akın S; Uckun FM
Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms.
Jiménez M; Fernández-Naval C; Navarro V; Novoa S; Martinez-Gallo M; Medina D; Andrés C; Antón A; Peralta S; Pujadas G; Hernández C; Pagès C; Roldán E; Pumarola T; Gironella M; Ruiz-Camps I; Martínez-Gómez X; Valcárcel D; Hernández M; Bosch F; Crespo M; Esperalba J; Abrisqueta P
Am J Hematol; 2023 Aug; 98(8):1204-1213. PubMed ID: 37151135
[TBL] [Abstract][Full Text] [Related]
24. Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
Storti P; Marchica V; Vescovini R; Franceschi V; Russo L; Notarfranchi L; Raimondi V; Toscani D; Burroughs Garcia J; Costa F; Dalla Palma B; Iannozzi NT; Sammarelli G; Donofrio G; Giuliani N
Oncoimmunology; 2022; 11(1):2120275. PubMed ID: 36105747
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 mRNA vaccine-induced immune responses in rheumatoid arthritis.
Limoges MA; Lortie A; Demontier É; Quenum AJI; Lessard F; Drouin Z; Carrier N; Nguimbus LM; Beaulieu MC; Boire G; Piché A; Allard-Chamard H; Ramanathan S; Roux S
J Leukoc Biol; 2023 Sep; 114(4):358-367. PubMed ID: 37478373
[TBL] [Abstract][Full Text] [Related]
26. Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine.
Huang R; Ying L; Wang J; Xia J; Zhang Y; Mao H; Zhang R; Zang R; Le Z; Shu Q; Xu J
Front Immunol; 2023; 14():1139620. PubMed ID: 37114058
[TBL] [Abstract][Full Text] [Related]
27. The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
Fiorino F; Ciabattini A; Sicuranza A; Pastore G; Santoni A; Simoncelli M; Polvere J; Galimberti S; Baratè C; Sammartano V; Montagnani F; Bocchia M; Medaglini D
Front Immunol; 2022; 13():1017863. PubMed ID: 36248803
[TBL] [Abstract][Full Text] [Related]
28. Functional SARS-CoV-2 cross-reactive CD4
Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg KJ; Lund-Johansen F; Aleman S; Björkhem-Bergman L; Jenmalm MC; Ljunggren HG; Buggert M; Karlsson AC
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2220320120. PubMed ID: 36917669
[TBL] [Abstract][Full Text] [Related]
29. Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia.
Engelmann R; Jaekel N; Jotschke S; Ludwig-Kraus B; Kraus FB; Kumari N; Schulze S; Hecker M; Zahn C; Al-Ali HK; Junghanss C; Böttcher S
Blood Adv; 2023 Jul; 7(14):3403-3415. PubMed ID: 36947191
[TBL] [Abstract][Full Text] [Related]
30. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
Schiavoni I; Palmieri A; Olivetta E; Leone P; Di Lonardo A; Mazzoli A; Cafariello C; Malara A; Palamara AT; Incalzi RA; Onder G; Stefanelli P; Fedele G;
J Am Med Dir Assoc; 2023 Feb; 24(2):140-147.e2. PubMed ID: 36587928
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 vaccination: Effects of immunodominant peptides of SARS-CoV-2.
Andrade AG; Comberlang FC; Cavalcante-Silva LHA; Kessen TSL
Cytokine; 2023 Oct; 170():156339. PubMed ID: 37607411
[TBL] [Abstract][Full Text] [Related]
32. Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies.
Chung DJ; Shah GL; Devlin SM; Ramanathan LV; Doddi S; Pessin MS; Hoover E; Marcello LT; Young JC; Boutemine SR; Serrano E; Sharan S; Momotaj S; Margetich L; Bravo CD; Papanicolaou GA; Kamboj M; Mato AR; Roeker LE; Hultcrantz M; Mailankody S; Lesokhin AM; Vardhana SA; Knorr DA
Blood Cancer Discov; 2021 Nov; 2(6):568-576. PubMed ID: 34778797
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
Taborska P; Lastovicka J; Stakheev D; Strizova Z; Bartunkova J; Smrz D
Immun Inflamm Dis; 2021 Dec; 9(4):1452-1467. PubMed ID: 34314576
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis.
Nemeth D; Vago H; Tothfalusi L; Ulakcsai Z; Becker D; Szabo Z; Rojkovich B; Merkely B; Nagy G
Front Immunol; 2022; 13():960001. PubMed ID: 36311767
[TBL] [Abstract][Full Text] [Related]
36. RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.
Bigenwald C; Haddad Y; Thelemaque C; Carrier A; Birebent R; Ly P; Flament C; Lahmar I; de Sousa E; Maeurer M; Miyara M; Assi T; Castilla-Llorente C; Willekens C; Fayemi C; Lazarovici J; Marabelle A; Derosa L; Ribrag V; Zitvogel L
Oncoimmunology; 2023; 12(1):2163785. PubMed ID: 36632566
[TBL] [Abstract][Full Text] [Related]
37. Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
Tortorella C; Aiello A; Gasperini C; Agrati C; Castilletti C; Ruggieri S; Meschi S; Matusali G; Colavita F; Farroni C; Cuzzi G; Cimini E; Tartaglia E; Vanini V; Prosperini L; Haggiag S; Galgani S; Quartuccio ME; Salmi A; Repele F; Altera AMG; Cristofanelli F; D'Abramo A; Bevilacqua N; Corpolongo A; Puro V; Vaia F; Capobianchi MR; Ippolito G; Nicastri E; Goletti D;
Neurology; 2022 Feb; 98(5):e541-e554. PubMed ID: 34810244
[TBL] [Abstract][Full Text] [Related]
38. T Cell Responses in Pregnant Women Who Received mRNA-Based Vaccination to Prevent COVID-19 Revealed Unknown Exposure to the Natural Infection and Numerous SARS-CoV-2-Specific CD4- CD8- Double Negative T Cells and Regulatory T Cells.
Chambers CD; Song J; da Silva Antunes R; Sette A; Franco A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396707
[TBL] [Abstract][Full Text] [Related]
39. Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies.
Greenberger LM; Saltzman LA; Gruenbaum LM; Xu J; Reddy ST; Senefeld JW; Johnson PW; Fields PA; Sanders C; DeGennaro LJ; Nichols GL
Blood Cancer Discov; 2022 Nov; 3(6):481-489. PubMed ID: 36074641
[TBL] [Abstract][Full Text] [Related]
40. Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.
Bergamaschi C; Pagoni M; Rosati M; Angel M; Tzannou I; Vlachou M; Darmani I; Ullah A; Bear J; Devasundaram S; Burns R; Baltadakis I; Gigantes S; Dimopoulos MA; Pavlakis GN; Terpos E; Felber BK
Front Immunol; 2022; 13():899972. PubMed ID: 35693807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
